The redundancy and overlap in multiple receptors and their signaling pathways, such as those seen in the roles of PKR, ZBP1, and MDA5 in the lethality associated with ADAR1 deficiency, could render single-target interventions ineffective, particularly in autoimmune diseases. This evidence concerns the gene ADAR and autoimmune disease.